You are here: Industry Insights > prices

News List

Report shows US brand-name drug prices ‘highest in the world’ europeanpharmaceuticalreview
May 08, 2019
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
Big pharma blamed for skyrocketing US drug prices europeanpharmaceuticalreview
April 12, 2019
Executives blamed high drug prices on the drugmakers and their pursuit of profits…
Medicaid misclassification bill inspired by EpiPen snafu passes Congress fiercepharma
April 10, 2019
How long does it take Congress to reach an agreement on drug prices? On the topic of drug misclassifications in Medicaid, about two and a half years.
In hiking prices, drugmakers show some signs of tempering increases PharmaSources/biopharmadive
March 26, 2019
In hiking prices, drugmakers show some signs of tempering increases
Oversight committee launches sweeping drug price investigation europeanpharmaceuticalreview
January 16, 2019
Chairman of the Committee on Oversight and Reform sends detailed requests to 12 pharmaceutical companies about increasing drug prices…
US lawmakers to introduce new bills to slash prescription drug prices pharmaceutical-technology
January 15, 2019
US Senator Bernie Sanders and Representative Elijah Cummings have announced plans to introduce three new bills to reduce the price of prescription drugs in the country.
Seniors want drug prices in ads. Young people? Eh, whatever: survey fiercepharma
November 15, 2018
Who wants drug prices in ads? Older people, that’s who. A recent survey by Wells Fargo Securities found that 77% of people 65 and older think pharma companies should be required to disclose prices in ads.
PhRMA blames hospitals for rising drug prices, hospitals association responds pharmafile
September 13, 2018
The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the furore around drug pricing continues in the United States of America...
Under scrutiny for Cohen deal, Novartis calls off further price hikes in 2018 fiercepharma
July 19, 2018
Even before Pfizer faced the wrath of U.S. President Donald Trump for July price hikes, Novartis decided against putting through more of its own increases in 2018, its helmsman told analysts on Wednesday.
The pendulum swing of generic drug prices pharmafile
August 21, 2017
The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to dramatic changes in the fiercely competitive market, as BCC Research's Laurie L. Sullivan and Paul Evers discuss.

Previous page 1 2 3 Next page